Optimizated Prolyl‐4‐Hydroxylase Expression in Komagataella phaffii Enables Efficient Triple‐Helix Formation of Recombinant Human Collagen
Biotechnology and Bioengineering · 2025-12 · 122 (12) · 3406-3417
DOI: 10.1002/bit.70055 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2025-09-02. Written by Nan Wang and 7 co-authors. Institution: Department of Biological Engineering, College of Life Sciences, Yantai University, Yantai, China. Major MEDLINE topics: Collagen, Prolyl Hydroxylases, Saccharomycetales. Cited 9 times so far (Crossref); 39 references. Funded by: This study was supported by the National Natural Science Foundation of China (No. 32001836), the Natural Science Foundation of Shandong Province (ZR20191118022….
Abstract (original language)
Prolyl‐4‐hydroxylase (P4H) catalyzes the hydroxylation of proline to hydroxyproline, a critical post‐translational modification essential for the formation and stability of collagen's triple‐helix structure. Although indispensable for recombinant human collagen (rhCol) production, P4H suffers from low expression levels, which significantly limit its industrial application. In this study, we achieved high‐level expression of P4H in Komagataella phaffii ( K. phaffii ), enabling the formation of the triple‐helix structure of rhCol. Initially, six codon‐optimized P4H genes were expressed in K. phaffii GS115, among which the Bacillus anthracis ‐derived BaP4H showed the highest expression level and was correctly localized to the endoplasmic reticulum, where efficient hydroxylation of collagen was facilitated. Subsequently, host strains screening identified K. phaffii X33 as the most productive, with an enzymatic activity of 6.64 × 10 3 U/L, representing to an 15.3% improvement over GS115. Further enhancement through promoter engineering and genomic integration site optimization increased enzymatic activity by 20.9%, reaching 8.03 × 10 3 U/L. Additional improvements via co‐expression of molecular chaperones and fusion with solubility‐enhancing tags elevated activity to 1.35 × 10⁴ U/L. Finally, co‐expression of the BaP4H with rhCol enabled the successful formation of the triple‐helical structure, which was not observed with rhCol expressed alone. This study establishes an effective strategy for optimizing P4H expression and enables the functional biosynthesis of recombinant collagen, with promising potential for biomedical and industrial applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biological Engineering, College of Life Sciences, Yantai University, Yantai, China.
- Yantai Key Laboratory of Characteristic Agricultural Bioresource Conservation and Germplasm Innovative Utilization, School of Life Sciences, Yantai University, Yantai, China.
- Institute of Future Food Technology, JITRI, Yixing, China.
- Yantai Zhenghai Biotechnology Co., Ltd, Yantai, China.
- Yantai Science and Technology Innovation Promotion Center, Yantai, China.
ORCID profiles: Hailing Zhang
Funding
- This study was supported by the National Natural Science Foundation of China (No. 32001836), the Natural Science Foundation of Shandong Province (ZR20191118022…
Cite
APA
Wang, N., Li, Y., Han, C., Ma, Y., Liu, Q., Sun, L., Wang, Y., & Zhang, H. (2025). Optimizated Prolyl‐4‐Hydroxylase Expression in Komagataella phaffii Enables Efficient Triple‐Helix Formation of Recombinant Human Collagen. Biotechnology and Bioengineering, 122(12), 3406-3417. https://doi.org/10.1002/bit.70055
Vancouver
Wang N, Li Y, Han C, Ma Y, Liu Q, Sun L, et al. Optimizated Prolyl‐4‐Hydroxylase Expression in Komagataella phaffii Enables Efficient Triple‐Helix Formation of Recombinant Human Collagen. Biotechnology and Bioengineering. 2025;122(12):3406-3417. doi:10.1002/bit.70055
BibTeX
@article{Wang2025,
author = {Wang, Nan and Li, Yang and Han, Chenxiao and Ma, Yaqian and Liu, Qisheng and Sun, Liqin and Wang, Yuan and Zhang, Hailing},
title = {Optimizated Prolyl‐4‐Hydroxylase Expression in Komagataella phaffii Enables Efficient Triple‐Helix Formation of Recombinant Human Collagen},
journal = {Biotechnology and Bioengineering},
year = {2025},
volume = {122},
number = {12},
pages = {3406--3417},
doi = {10.1002/bit.70055}
}
EUVIMED